The Washington Post Reports On New Bioterror Legislation -- Aethlon Medical Referenced As A Potential Beneficiary

SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, disclosed today that The Washington Post has reported on the passage of legislation by the House and Senate that establishes The Biomedical Advanced Research and Development Authority (BARDA). As referenced in the story, Aethlon Medical is a potential beneficiary of the legislation, which President Bush is likely to sign into law.
MORE ON THIS TOPIC